Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Boston Convention and Exhibition Center

Jun 23, 2013 8:30 AM - Jun 27, 2013 12:45 PM

415 Summer Street, , Boston, MA 02210 , USA

DIA 2013 49th Annual Meeting: Advancing Therapeutic Innovation and Regulatory Science

eSource Symposium

Session Chair(s)

Chris  Ramm

Chris Ramm

Clinical Ink, United States

A Common Tool for Investigator Site eSource (EHRS) Readiness Assessment

Learning Objective : Discuss the principles of risk-based approaches to successfully using esource clinical data; Identify how to implement a risk-based study monitoring approach to electronic clinical data; Describe methods to successfully assess electronic health records systems that will be used for clinical data.

Speaker(s)

Catherine  Celingant, MA

A Common Tool for Investigator Site eSource (EHRS) Readiness Assessment

Catherine Celingant, MA

Pfizer Inc, United States

Executive Director, Data Monitoring and Management, Oncology Therapeutics Lead

Chris  Ramm

Chris Ramm

Clinical Ink, United States

Jules  Mitchel, PhD, MBA

Time to Change the Clinical Trial Monitoring Paradigm: Results From Clinical Trials Using eSource and Risk-based Monitoring

Jules Mitchel, PhD, MBA

THI Pharma Services, United States

President and CEO

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.